Clinical Trial Update: Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating umbilical cord mesenchymal stem cell transfusion for decompensated liver cirrhosis. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Liver Cirrhosis

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shandong Qilu Stem Cells Engineering Co., Ltd. | Conditions: Decompensated Liver Cirrhosis | Phase 2 | Status: UNKNOWN